The Faculty of Pharmacy and Pharmaceutical Sciences is pleased to share a video highlighting the significant moments of its World War One posthumous degree ceremony on Tuesday April 30.
Monash University announced today the grant of an exclusive licence of its portfolio of proprietary synthetic polymyxin antibiotics to Qpex Biopharma, a US-based biopharmaceutical company focused on developing new antibiotics to combat the
Collaboration will use technology licensed to PureTech Health to develop Boehringer Ingelheim’s novel immuno-oncology product candidates
Monash University researchers have trialled a new model of care for people living with chronic obstructive pulmonary disease (COPD) that could improve their quality of life considerably.
The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.
Inosi Therapeutics launched to tackle fibrosis, based on science from Monash University and support from IP Group and BioCurate
Inosi Therapeutics, a company based on research at Monash University, has launched with an investment from IP Group and BioCurate.
Monash University ranked #1 Pharmacy program, and top 3 in the world in Pharmacy and Pharmacology, for the third consecutive year
The 2019 QS World University Rankings by Subject have ranked Monash University in the top three in the world in Pharmacy and Pharmacology, making it the number one ranked Pharmacy program.
PharmAlliance, the research, professional practice and education partnership between the Schools of Pharmacy at Monash University, University College London (UCL) and the University of North Carolina at Chapel Hill (UNC), has held its